期刊文献+

Polo-like激酶l反义RNA对肺癌细胞A549生长的实验研究

Effect of antisense RNA targeting Polo-like kinase 1 on cell growth in A549 lung cancer cells
下载PDF
导出
摘要 目的:探讨Polo-like激酶1(Plk1)基因表达下调对肺癌细胞周期分布及其生长的影响。方法:培养肺腺癌细胞株A549,构建表达Plk1反义RNA的质粒pcDNA3-Plk1,通过脂质体介导转染A549细胞,采用RT-PCR和Western blotting的方法检测Plk1基因的表达,细胞计数、BrdU脉冲标记检测细胞增殖,流式细胞仪分析细胞周期变化和凋亡,MTT法检测长春瑞宾(NVB)对各组细胞的生长抑制率。结果:A549细胞转染pcDNA3-Plk1后24h,Plk1mRNA及蛋白表达均下降;细胞变圆、漂浮、增殖减慢;S期细胞百分数(BrdU标记指数)显著低于对照组(P<0.05);转染后48hA549细胞出现G2/M期阻滞(P<0.05)并发生凋亡;等浓度化疗药物诺维本对转染pcDNA3-Plk1细胞的抑制率明显高于各对照组(P<0.05),转染pcDNA3与未转染的对照细胞差异无显著(P>0.05)。结论:pcDNA3-Plk1的转染能下调Plk1基因的表达,抑制A549细胞增殖,诱导凋亡,并能增加A549细胞对化疗药物的敏感性。 AIM : To investigate the effect of Polo - like kinase - 1 ( Plkl ) depletion on cell cycle progression and cell growth in lung cancer cells, METHODS: A recombinant plasmid containing antisense RNA targeting Plkl (pcD- NA3 - Plkl ) was transfected into A549 cells by lipofectine. RT - PCR and Western blotting were used to examine Plkl gene expression. Cell proliferation was evaluated by cell counting and BrdU labeling. Cell cycle distribution and apoptosis were examined by flow cytometry. Inhibition rate (IR) of vinorebline (NVB) was determined by MTT assay. RESULTS: After transfected with pcDNA3 - Plkl into A549 cells, the expression levels of Plkl mRNA and protein were greatly decreased. Abnormal morphological changes of cells and growth inhibition were observed in pcDNA3 - Plkl transfected cells. The BrdU labeling index was significantly lower than that in control group (P〈0. 05 ). Cells showed a strong G2/M arrest and apoptosis 72 h post transfection. IR of vinorebline in pcDNA3 - Plkl transfected groups was significantly higher than that in other groups. CONCLUSION : Antisense RNA targeting Plkl is capable of suppressing Plkl expression, and therefore, significantly inhibits cellular proliferation, induces cell cycle arrest and apoptosis. Moreover, the sensitivity of lung cancer cells to chemotherapy is increased.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2007年第7期1352-1356,共5页 Chinese Journal of Pathophysiology
关键词 Polo—like kinase-1 RNA 反义 细胞周期 肺肿瘤 Polo - like kinase - 1 RNA, antisense Cell cycle Lung neoplasms
  • 相关文献

参考文献13

  • 1Donaldson MM,Tavares AA,Hagan IM,et al.The mitotic roles of Polo-like kinase[J].J Cell Sci,2001,114(Pt 13):2357-2358.
  • 2van Vugt MA,Bras A,Medema RH.Restarting the cell cycle when the checkpoint comes to a halt[J].Cancer Res,2005,65(16):7037-7040.
  • 3Takai N,Hamanaka R,Yoshimatsu J,et al.Polo-like kinases (Plks) and cancer[J].Oncogene,2005,24(2):287-291.
  • 4Jung M,Grunberg S,Timblin C,et al.Paclitaxel and vinorelbine cause synergistic increase in apoptosis but not in microtubular disruption in human lung adenocaconoma cells(A-549)[J].Histochem Cell Biol,2004,121(2):115-121.
  • 5周廷潮,韩锐,胥彬.多种药物协同及拮抗作用的定量分析原理在化疗中的应用[A].见:韩锐主编.肿瘤化学预防及药物治疗[M].北京:北京医科大学中国协和医科大学联合出版社,1991.315.
  • 6van Vugt MA,Smits VA,Klompmarker R,et al.Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM-or ATR-dependent fashion[J].J Biol Chem,2001,276(45):41656-41660.
  • 7Roshak AK,Capper EA,Imburgia C,et al.The human Polo-like kinase,PLK,regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase[J].Cell Signal,2000,12(6):405-411.
  • 8Toyoshima-Morimoto F,Taniguchi E,Nishida E.Plk1 promotes nuclear translocation of human Cdc25C during prophase[J].EMBO Rep,2002,3(4):341-348.
  • 9Liu X,Erikson RL.Activationof Cdc2/cyclin B and inhibition of cenreosome amplification in cells depleted of Plk1 by siRNA[J].Proc Natl Acad Sci,2002,99(13):8672-8676.
  • 10van Vugt MA,van De Weerdt BC,Vader G,et al.Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis[J].J Biol Chem,2004,279(35):36841-36854.

二级参考文献42

  • 1Pozniak CD, Radinovic S, Yang A, et al . An anti-apoptotic role for the p53 family member, p73, during developmental neuron death[J]. Science, 2000, 289(5477): 304-306.
  • 2Grassme H, Kirschnek S, Riethmueller J, et al. CD95/CD95 ligand interactions on epithelial cells in host defense to psedomonas aeruginosa[J]. Science, 2000, 290(5491): 527-530.
  • 3Wajant H. The Fas signaling pathway: more than a paradigm[J]. Science, 2002, 296(5537): 1635-1636.
  • 4Itoh N, Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen[J]. J Biol Chem, 1993, 268(15): 10932-10937.
  • 5Siegel RM, Frederiksen JK, Zacharias DA, et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations[J]. Science, 2000, 288(5475): 2354-2357.
  • 6Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway[J]. Science, 2002, 297(5573): 1634-1635.
  • 7Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis[J]. Bioessays, 2003, 25(1): 17-24.
  • 8Chen X, Shen B, Xia L, et al. Activation of nuclear factor kappa B in radinoresistance of TP53-inactive human keratinocytes[J]. Cancer Res, 2002, 62(4): 1213-1212.
  • 9Komarov PG, Komarova EA, Kondratov RV, et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy[J]. Science, 1999, 285(5434): 1733-1737.
  • 10Yu JL, Rak JW, Coomber BL, et al. Effect of p53 status on tumor response to antiangiogenic therapy[J]. Science,2002, 295(5559): 1526-1528.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部